Donate
|
Join/Renew
|
Store
|
Member Directory
|
My SNMMI
Search SNMMI.org
Search SNMMI Learning Center
Value Initiative
|
Physicians
|
Technologists
|
Scientists
|
Residents
|
Healthcare Provider
|
Patients
NEWS & PUBLICATIONS
News and Media
Newsletters
Journals
Books
MEMBERSHIP
Join/Renew
Benefits
Categories
Download a Member Application
Grants, Awards, and Scholarships
Access the Phantom Analysis Toolkit
Membership Directory
Chapters
Centers of Excellence
Councils
Member Spotlight
Women in Nuclear Medicine
SNMMI Fellow
SNMMI-TS Fellow
Council and Center Internships
EDUCATION
Learning Center
Webinars
MEETINGS & EVENTS
Calendar of Events
Webinars
2024 Annual Meeting
2024 Therapeutics Conference
2024 Mid-Winter Meeting
Nuclear Medicine & Molecular Imaging Week
ADVOCACY
Coding & Reimbursement
Legislative Efforts
Government Relations News
Radiopharmaceutical Supply News
USP 825
Technologist State Issues
Position Statements
FDA PET Drug Manufacturing Q&A
EVIDENCE & QUALITY
Clinical Guidelines and AUC
Quality
Quality and Patient Safety
Dose Optimization
About Quality & Practice
Dosimetry
RESEARCH
Clinical Trials Network
Radiopharmaceutical Therapy Central
Radiopharmaceutical Therapy Centers of Excellence
Preclinical Imaging
Nuclear Medicine Clinical Trial Group, LLC
Research: Learn More
ABOUT SNMMI
Strategic Plan
Bylaws & Procedures
Governance - SNMMI
Governance - SNMMI-TS
History
Grants, Awards, and Scholarships
Career Center
About Nuclear Medicine & Molecular Imaging
International Collaboration
Outreach
Support SNMMI
Contact Us
HOME
>
SEARCH
>
SEARCH RESULTS
Refine by Audience:
Physicians
(212)
Technologists
(211)
Scientists
(197)
Media
(188)
Patients
(174)
International
(154)
Selected filters:
Healthcare Provider
Displaying 41 to 50 of 246 records
Sort by:
Relevancy
Date Added
Page:
<< Prev
2
…
3
…
4
…
5
…
6
…
7
…
8
…
Next >>
CMS Releases Final Rule on the Hospital Outpatient Prospective Payment System
– Dec 7, 2023
In early November, CMS released the Hospital Outpatient Prospective Payment System (OPPS) CY 2024 final rule.
Journal of Nuclear Medicine Supplement Explores Nuclear Cardiology
– Nov 20, 2023
A new JNM supplement highlights the exciting new developments and opportunities for nuclear cardiology in the modern era of personalized cardiovascular medicine.
Novel PET Radiotracer Facilitates Early, Noninvasive Detection of Inflammatory Bowel Disease
– Nov 14, 2023
A newly developed PET radiotracer can be used to create an inflammation map of the entire gastrointestinal tract, providing detailed information to accurately detect and stage inflammatory bowel disease, according to research published in JNM.
Bone Scans Overstage Prostate Cancer at Initial Staging Compared with PSMA PET
– Nov 9, 2023
Bone scans have been found to overstage prostate cancer at initial staging compared to PSMA PET, according to new research published in JNM.
New AI Tool for PET Imaging Allows for High-Quality, Fully Automated Evaluation of Brain Tumors
– Oct 17, 2023
A new artificial intelligence tool provides a fully automated, easy-to-use and objective way to detect and evaluate brain tumors, according to new research published in JNM.
PET Imaging Validates Use of Common Cholesterol Drug to Enhance HER2-Targeted Cancer Therapy
– Oct 12, 2023
A novel therapeutic approach combining HER2-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth, according to research published in JNM.
PET/CT in Oncology-Part 2
– Oct 11, 2023
Editors: Kathy S. Thomas, MHA, CNMT, PET, FSNMMI-TSMary Beth Farrell, MS, CNMT, NCT, FSNMMI-TSNuclear medicine professionals performing PET/CT in oncology must have the most up-to-date scientific and technical information to produce and interpret high-quality data to support optimal patient care. PET/CT in Oncology, Part 2, provides information on 10 areas of care:PET/CT—Basic Science, PET/MR—Basic SciencePET/CT Imaging in Thyroid and Adrenal CancerPET/CT Imaging in Lung CancerPET/CT Imaging in Gastric and Esophageal CancersPET/CT Imaging in Pancreatic and Liver CancerPET/CT Imaging in Malignant MelanomasPET/CT Imaging in LymphomaPET/CT Imaging and RadiotherapyFuture PET Applications in PET Oncology.As with previous books in the Quality and Safety Series, content follows a standard format, including incidence, etiology, epidemiology, histopathology, conventional diagnostic procedures, imaging, technical recommendations, and references/suggested readings.152 pages | ISBN: 978-0-932004-41-3 | Release date: March 2022 SNMMI Members: Download your free digital copy.
Novel Tau PET Tracer Exhibits High Sensitivity and Specificity, Allowing for Earlier Identification of Alzheimers Disease
– Sep 28, 2023
A new tau PET radiotracer, F-18 SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimers disease in its earliest stages, according to research published in JNM.
Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients
– Sep 27, 2023
A new imaging agent, Ga-68-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in JNM.
First Three Facilities Accredited in SNMMI/IAC Radiopharmaceutical Therapy Accreditation Program
– Sep 25, 2023
SNMMI and the Intersocietal Accreditation Commission are pleased to announce the first three facilities to be awarded the new Radiopharmaceutical Therapy Accreditation.
Displaying 41 to 50 of 246 records
Page:
<< Prev
2
…
3
…
4
…
5
…
6
…
7
…
8
…
Next >>
Didn't find what you were looking for? Conduct a new search.